Tai United Holdings (0718) Fair Value & Analysis
Healthcare · HK · Market cap HK$168M
Fair value as of: Aug 13, 2026
From 6 valuation models · updated 2 days ago
Fair value updated Aug 13, 2026, revised from HK$0.0508 to HK$0.0438 (−13.7%) since Aug 5, 2026. Share price −14.7% over the past month.
A solid business, screening 51% undervalued on our models.
What matters now
- The price is below even our cautious bear case (HK$0.0351). The market is more pessimistic than our downside scenario.
- The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
- Solid quality (51/100) at a price below fair value, the discount is the argument here, not the business quality.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
60‑month range HK$0.0170 – HK$0.2290 · fair‑value band HK$0.0351 – HK$0.0554 · the HK$0.0290 price screens below the HK$0.0438 fair value. Dashed = 300-day average. As of Aug 13, 2026.
Analysis
Tai United Holdings (0718) currently trades at HK$0.0290, while our model-based Fair Value estimate is HK$0.0438, implying the stock looks roughly 51.0% undervalued today. The Quality Score stands at 51/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low), always confirm before acting.
Trailing-twelve-month revenue stands at HK$126M. Revenue grew 24.8% year over year. Net debt stands at HK$1.4B. Fundamentals as of Aug 13, 2026
Our scenario range runs from HK$0.0351 (bear case) to HK$0.0554 (bull case); at HK$0.0290, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 60% below its 52-week high and 4% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -7% fair-value upside, at 51%, 0718 screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 6 models by family
Widest divergence: DCF Models (HK$0.0800) versus Multiples (HK$0.0600). Highest evidence: Growth DCF (80).
Notify me when 0718 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 47 · Market factors (momentum, volatility) 24
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Tai United Holdings Limited, an investment holding company, primarily invests in properties in the People's Republic of China, the United States, the United Kingdom, Australia, and Belgium.
Full company description
Tai United Holdings Limited, an investment holding company, primarily invests in properties in the People's Republic of China, the United States, the United Kingdom, Australia, and Belgium. The company operates through Properties Investment, Sales of Medical Equipment, Sales of Flooring Materials, Mining and Exploitation of Natural Resources, and Financial Services and Assets Management segments. Its Properties Investment segment invests in, manages, and leases residential and shopping properties, as well as develops shopping malls. The Sales of Medical Equipment segment trades in medical equipment. Its Sales of Flooring Materials segment trades in flooring materials. The Mining and Exploitation of Natural Resources segment is involved in mining and production of tungsten resources activities in the Republic of Mongolia. Its Financial Services and Assets Management segment trades in equity securities and derivatives; and manages assets arising from acquisition of distressed debts assets. The company was formerly known as Bestway International Holdings Limited and changed its name to Tai United Holdings Limited in August 2016. The company was incorporated in 1995 and is headquartered in Wan Chai, Hong Kong. Tai United Holdings Limited operates as a subsidiary of Songbird SG PTE. Ltd.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Tai United Holdings reported revenue of HK$125M in FY2025 versus HK$309M in FY2021, a compound −20.2%/yr. Reported net income was −HK$372M in FY2025.
Watch 0718: get an alert when its fair value changes →
Peer Group
Medical Distribution · 77 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Distribution median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Distribution stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| McKesson Corporation MCK | $878.73 | $819.31 | -7% |
| Cencora, Inc COR | $314.17 | $211.07 | -33% |
| Cardinal Health, Inc CAH | $234.16 | $141.77 | -39% |
| Henry Schein, Inc HSIC | $90.74 | $71.70 | -21% |
| Shanghai Pharmaceuticals Holding 601607 | ¥16.56 | ¥33.96 | +105% |
| Sinopharm Group 1099 | HK$16.75 | HK$58.67 | +250% |
| Galenica AG GALE | CHF 80.85 | CHF 61.79 | -24% |
| Guangzhou Baiyunshan Pharmaceutical Holdings 600332 | ¥21.49 | ¥28.65 | +33% |
| Jointown Pharmaceutical Group 600998 | ¥5.04 | ¥9.84 | +95% |
| Asker Healthcare Group ASKER | kr 80.00 | kr 28.26 | -65% |
Compare Tai United Holdings with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Tai United Holdings (0718) overvalued or undervalued?
What is the fair value of 0718?
What is the quality score of 0718?
What is the revenue of Tai United Holdings (0718)?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Tai United Holdings and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.